Top 7 Leading Virtual Biopsy Companies

Published: August 2025

Biopsy is defined as a procedure of removing or extracting tissue from the body through various methods, such as surgical, needle, laparoscopic techniques. This procedure plays a crucial role in the diagnosis or monitoring of certain medical conditions such as inflammatory disorders, immune disorders, oncological conditions, and several infections. By analyzing the cellular composition of the extracted tissue, healthcare experts can gain detailed insights into the patient’s condition.

Despite its diagnostic importance, biopsy is an invasive technique which can cause pain, discomfort and may lead to severe complications, such as bleeding and infections. To mitigate these issues, advancements in medical technology have led to the development of less invasive techniques, such as virtual biopsy.

Virtual biopsy is an emerging technique in the field of healthcare, which utilizes various imaging techniques, such as radiomics, optical coherence tomography (OCT) and impedance spectroscopy to non-invasively acquire images of the target site. These images are further analyzed to examine and assess the patient’s condition without the need for conventional invasive biopsy procedures.

In recent years, the virtual biopsy companies have witnessed several advancements. This progress is primarily attributed to an increased research and development aimed at creating more robust models for quantifying and analyzing virtual biopsy data. These improvements facilitate more efficient diagnosis and prognosis of diseases within the healthcare sector. In addition to model development and validation, there is a critical need for the collection of large datasets, comprehensive annotation and the expansion of storage capacities to accommodate high-quality, high-depth images. Such measures are essential for models to accurately reference datasets, enabling them to identify patterns and analyze the intricacies of cellular and subcellular compositions across various tissues.

Roots Analysis has conducted an exhaustive study on Virtual Biopsy Market featuring the current market landscape and future opportunity for the virtual biopsy companies engaged in the development of virtual biopsy devices, over a span of 10 years.

Below, we have listed (in alphabetical order), the top 7 virtual biopsy companies.

GE Healthcare
ImageBiopsy Lab
Imaging Biometrics
Median Technologies
OptoVibronex
Quibim
Siemens Healthineers

Top 7 Virtual Biopsy Companies

Interested in exploring key virtual biopsy companies and their recent initiatives?

Discover Below the Details on Top 7 Virtual Biopsy Companies

Let us deep dive to understand the activity of the 7 top virtual biopsy companies engaged in the development of virtual biopsy devices. It is essential to note that the selection of top players can differ substantially according to the defined criteria.

GE Healthcare has Received DICOM and CE Accreditations for Medical Imaging Devices and Affiliated Software Which Ensures That Their Products Meet High-quality Healthcare Standards

1. GE Healthcare

GE HealthCare in a global medical technology and digital solution provider specialized in advanced healthcare services such as imaging, patient monitoring and workflow management. The company operates across different business segments, including imaging, ultrasound, patient care solutions and pharmaceutical diagnostics. By leveraging these segments, GE HealthCare integrates artificial intelligence (AI) and advance analytics with imaging technologies to offer innovative solutions, such as virtual biopsy. To facilitate efficient data analysis, the firm has developed the Edison platform, which utilizes AI, machine learning (ML) and deep learning algorithms affiliated software in order to identify imaging patterns for providing clinical suggestions.

GE Healthcare: Company Details

Particulars	Specifications
Company Logo
Year of Establishment	1892
Number of Employees	10,001+
Headquarters
Virtual Biopsy Devices Offered	Colon VCAR CTC Pro3D EC

In April 2025, GE Healthcare participated in Society of Breast Imaging Symposium in Colorado Springs, held in Colorado, US to showcase its latest advancements in diagnostic accuracy and patient-centered breast care.

Further details on recent initiatives taken by GE Healthcare and other virtual biopsy companies have been provided in detail in the report.

ImagingBiopsy Lab Leveraging its AI-driven Analysis, to Improve Diagnostic Accuracy and Streamline Workflows for Radiologists and Orthopedic Specialists

2. ImageBiopsy Lab

ImageBiopsy Lab is an AI powered software company that leverages advanced software solutions to analyze medical imaging for musculoskeletal (MSK) disorders. The company has developed a diverse portfolio of products under Lab ZOO, utilizing X-Ray and CT imaging to quantify and analyze discrepancies in MSK. The Lab ZOO portfolio is designed to assist healthcare professionals in making informed decisions, thereby enhancing patient management and treatment. It is worth highlighting that this software is designed for early disease detection and management of MSK disorders.

ImageBiopsy Lab: Company Overview

Particulars	Specifications
Company Logo
Year of Establishment	2016
Number of Employees	11-50
Headquarters
Virtual Biopsy Devices Offered	HIPPO™ IB Lab FLAMINGO IB Lab FROG IB Lab SQUIRREL™ KOALA™ LAMA™ PANDA™

Further details on recent initiatives taken by ImageBiopsy Lab and other virtual biopsy companies have been provided in detail in the report.

In March 2018, Imaging Biometrics was acquired by UK based IQ-AI

3. Imaging Biometrics

Imaging Biometrics specializes in developing ready to use analytical software solutions tailored for the healthcare industry. The company operates under the trade name IB Clinic and offers a diverse range of analytical tools that analyze MRI and CT medical imaging, providing valuable insights such as tumour grading and predictions of tumour regrowth regions. The software also generates quantitative parameter maps in DICOM format, aiding physicians in delivering validated treatment approaches and improving patient care management.

Further, the company provides workflow engines under the name of IB Rad Tech, which optimize image maps and reduced the time to generate analytical maps by ~75%. By integrating advanced data analysis software into existing workflows, Imaging Biometrics helps healthcare providers obtain faster and more accurate medical results.

Imaging Biometrics: Company Overview

Particulars	Specifications
Company Logo
Year of Establishment	2007
Number of Employees	2-10
Headquarters
Virtual Biopsy Devices Offered	IB DCE™ IB Delta Suite™ (IB Rad Tech™ workflow engine) IB DIFFUSION IB NEURO™ Stonechecker

The company also distributes LSN (Liver Surface Nodularity) module developed by AI Metrics. This module uses AI to process liver CT images for virtual liver biopsy.

Further details on recent initiatives taken by Imaging Biometrics and other virtual biopsy companies have been provided in detail in the report.

Median Technologies Has Been Recognized as an Innovative Company by BPI and is Listed on the Euronext Growth Market in Paris

4. Median Technologies

Median Technologies is an imaging solution and diagnostic service provider in healthcare domain. The company utilizes artificial intelligence, computer vision and signal processing technologies to deliver valuable insights from medical images to physicians. Median Technologies offers a range of virtual biopsy products under the trade name of eyonis to improve patient care management.

It is worth noting that the company has its own proprietary AI/ML technology-based software, known as CADe/CADx SaMDs, that facilitates earlier disease diagnosis and continuous monitoring throughout the patient journey, ensuring efficient and accurate analysis of patients' conditions. Additionally, the company is engaged in clinical trials on oncological imaging, drug development and precision medicines to cater to the unmet medical demands. This recognition aids the company in raising funds for further growth.

Further, it has been selected for support by the French government's ETIncelles program, which assists companies in becoming intermediate-sized enterprises (ETIs). Through these initiatives, Median Technologies continues to strengthen its position in the market and enhance its contributions to modern healthcare.

Median Technologies: Company Overview

Particulars	Specifications
Company Logo
Year of Establishment	2002
Number of Employees	201-500
Headquarters
Virtual Biopsy Devices Offered	eyonis™HCC eyonis™IPN eyonis™LCS

In 2025, Median Technologies is poised to launch its first AI-powered Software as a Medical Device (SaMD), eyonis™ LCS, for lung cancer screening.

Further details on recent initiatives taken by Median Technologies and other virtual biopsy companies have been provided in detail in the report.

OptoVibronex is a Participant in the Advanced Research Projects Agency for Health (ARPA-H), Focusing on the Development of Transformative Healthcare Solutions

5. OptoVibronex

OptoVibronex is an advanced medical imaging technology company offering non-invasive virtual biopsy devices aimed at enhancing diagnosis in the healthcare industry. The company has developed patented imaging technology known as vibrational optical coherence tomography (VOCT), which is integrates analysis software to provide information detailed 2D and 3D images, along with information about tissue elasticity and viscosity. This capability allows for a comprehensive diagnosis of patients’ health condition, and aids in differentiating between benign and malignant cells.

Moreover, VOCT technology used by the company utilizes near infra-red light and audible sound, making the virtual biopsy process safer for patients. This non-invasive approach reduces the risks typically associated with traditional biopsies. Through these innovations, OptoVibronex aims to significantly improve patient outcomes by providing advanced virtual biopsy devices that enhance diagnostic accuracy and treatment planning.

OptoVibronex: Company Overview

Particulars	Specifications
Company Logo
Year of Establishment	2016
Number of Employees	2-10
Headquarters
Virtual Biopsy Devices Offered	OptoScope 2.0™ Vibrational Optical Coherence Tomography (VOCT)

In March 2024, the company was selected as a member of Advanced Research Projects Agency for Health (ARPA-H) Investor Catalyst Hub Spoke Network, a research funding agency that supports transformative healthcare advancements.

Further details on recent initiatives taken by OptoVibronex and other virtual biopsy companies have been provided in detail in the report.

Quibim’s Virtual Biopsy Products Received ISO, FDA and CE Clearances, Ensuring the Delivery of High-quality Products to Consumers

6. Quibim

Quibim is a biotechnology research company specializing in the management, storage and processing of multi-omics data, which includes medical images obtained from magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET). The company has developed fully automated image quantification systems that utilize artificial intelligence (AI) to analyze disease severity in patients and generate structured reports. This process adheres to stringent data privacy policies through its QP-Link software, which facilitates secure data transfer between health institutes and cloud image storage systems. Quibim offers a range of innovative virtual biopsy products designed to enhance diagnostic processes and improve patient outcomes through advanced imaging technologies.

Quibim: Company Overview

Particulars	Specifications
Company Logo
Year of Establishment	2015
Number of Employees	51-200
Headquarters
Virtual Biopsy Devices Offered	QP-Brain® QP-Breast® QP-Liver® QP-Lung® QP-Prostate®

In January 2025, Quibim raised USD 50 million in a Series A venture capital round led by Asabys Partners and Buenavista, with participation from UI Investissements, GoHub Ventures, Amadeus Capital Partners, APEX Ventures, Partech, Adara Ventures, Leadwind, Build Collective, and others, to further innovate its tools for MRI, CT, and PET imaging to detect tumors and other diseases.

Further details on recent initiatives taken by Quibim and other virtual biopsy companies have been provided in detail in the report.

Siemens Healthineers is Engaged With Researchers, Partners, Caregivers, and Global Institutions to Further Strengthen Research and Development in the Virtual Biopsy Domain

7. Siemens Healthineers

Siemens Healthineers is a medtech company that offers a comprehensive array of products designed to provide virtual biopsy solutions in the healthcare industry. Along with this, the company emphasizes personalized care, precision therapy and technology enabled workflow operations to assist physicians in making technology-validated decisions. To enhance its market presence, Siemens Healthineers is committed to continuous research and development, integrating innovative solutions into its device portfolio.

Siemen Healthineers: Company Overview

Particulars	Specifications
Company Logo
Year of Establishment	1896
Number of Employees	10,001+
Headquarters
Virtual Biopsy Devices Offered	BreVis Biopsy Virtual Touch™ Applications Virtual Touch IQ

Further details on recent initiatives taken by Siemens Healthineers and other virtual biopsy companies have been provided in detail in the report.

What About the Other Virtual Biopsy Companies Around the World?

The above presentation features 7 top virtual biopsy companies selected from a pool of ~25 players that we have compiled, engaged in the development of ~45 virtual biopsy devices. If you're interested, you can download the Sample Report on this topic by Roots Analysis. For personalized assistance in identifying the most relevant solutions based on your specific criteria, please don't hesitate to reach out to us at sales@rootsanalysis.com.

Sources